Evaluation of optimization workflow using custom-made planning through predicted dose distribution for head and neck tumor treatment.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 15 07 2020
revised: 14 10 2020
accepted: 29 10 2020
pubmed: 15 11 2020
medline: 25 6 2021
entrez: 14 11 2020
Statut: ppublish

Résumé

Lack of a reference dose distribution is one of the challenges in the treatment planning used in volumetric modulated arc therapy because numerous manual processes result from variations in the location and size of a tumor in different cases. In this study, a predicted dose distribution was generated using two independent methods. Treatment planning using the predicted distribution was compared with the clinical value, and its efficacy was evaluated. Computed tomography scans of 81 patients with oropharynx or hypopharynx tumors were acquired retrospectively. The predicted dose distributions were determined using a modified filtered back projection (mFBP) and a hierarchically densely connected U-net (HD-Unet). Optimization parameters were extracted from the predicted distribution, and the optimized dose distribution was obtained using a commercial treatment planning system. In the test data from ten patients, significant differences between the mFBP and clinical plan were observed for the maximum dose of the brain stem, spinal cord, and mean dose of the larynx. A significant difference between the dose distributions from the HD-Unet dose and the clinical plan was observed for the mean dose of the left parotid gland. In both cases, the equivalent coverage and flatness of the clinical plan were observed for the tumor target. The predicted dose distribution was generated using two approaches. In the case of the mFBP approach, no prior learning, such as deep learning, is required; therefore, the accuracy and efficiency of treatment planning will be improved even for sites where sufficient training data are unavailable.

Identifiants

pubmed: 33189047
pii: S1120-1797(20)30271-4
doi: 10.1016/j.ejmp.2020.10.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-174

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Kentaro Miki (K)

Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan. Electronic address: kentaro-miki@hiroshima-u.ac.jp.

Martijn Kusters (M)

Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Takeo Nakashima (T)

Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan.

Akito Saito (A)

Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan.

Daisuke Kawahara (D)

Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

Ikuno Nishibuchi (I)

Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan; Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

Tomoki Kimura (T)

Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan.

Yuji Murakami (Y)

Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan; Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

Yasushi Nagata (Y)

Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan; Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH